Home
About
Editorial
Cover Stories
Advertising
Submissions
Contact

Visit Our Advertisers

Article Archive

---

Sequoia Hospital First in Northern California to Use New X-Ray Technology on Skin Cancer

Sequoia Hospital announced the use of the new Gulmay Xstrahl 100, a form of low energy x-ray therapy used for treating cancerous skin lesions such as basal cell and squamous cell carcinomas. Superficial radiation therapy has been used to treat skin cancers for the past 70 years and remains one of the most successful treatments for basal cell carcinoma (BCC). The Gulmay Xstrahl 100 can treat a wide variety of skin cancers because of a unique design: simple beam direction and modification, unrestricted applicator positioning and flexible set-up allow for excellent cosmetic outcomes. Cancers on places that are difficult to treat, such as a patient’s nose, can now be treated with x-ray technology rather than disfiguring surgery.

 

Because of the flexible design, the Gulmay Xstrahl 100 is considered the preferred method of treatment for skin cancers on the face and on the shin area of the legs, where surgery can be difficult. “With the new Gulmay Xstrahl 100, we now have the ability to treat an incredible array of skin cancers in terms of size and thickness of the cancer,” said Bay Area radiation oncologist C. Dale Young, M.D. “At Sequoia Hospital our cure rates for BCC using superficial radiation therapy fall in the 95-98% range. This new technology is a significant advance in how we treat many skin cancers with radiation therapy.”

---